VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 1065453
Sex: M
Age: 74
State: CT

Vax Date: 02/18/2021
Onset Date: 02/28/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies: Bioxin

Symptoms: Rash, soreness when touched, itchy

Other Meds: Lipitor, Afluzosin, Losartan, Dutasteride

Current Illness:

ID: 1065454
Sex: F
Age: 39
State: OH

Vax Date: 02/28/2021
Onset Date: 02/28/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies: None known

Symptoms: Burning and redness in both armpits, fever of 100.0 Fahrenheit, headache, fatigue.

Other Meds: Adderall XR, Levothyroxine, Cytomel, Oral contraceptives, sonata

Current Illness: None

ID: 1065455
Sex: F
Age: 61
State: FL

Vax Date: 02/18/2021
Onset Date: 03/01/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies: Ceclor, contrast dye

Symptoms: Red swollen circle 2.5 inches around injection site

Other Meds: Levothyroxine 175 mcgs x 1 Gabapentin 300 mg x2 metformin 1000 mg x 2 Anastrozole 1 mg arimedex x 1 Lisinipril 10 Atorvastain 40 mg Calcium 500mg x1 D3 125 mcg Bayer81 mg B complex

Current Illness:

ID: 1065456
Sex: F
Age: 70
State: WI

Vax Date: 02/14/2021
Onset Date: 02/26/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies: Dairy, yeast and mold, nightshades, wheat, corn, Versed, benzalkonium chloride, thimerosal, hay fever (tree and grass pollen) dust mites, wasp venom, iodine, chlorhexadine, diazepam, tramadol, adhesive, Sudafed, gentamicin, contrast media, carisoprodol, tobacco, fluorometholone, cinnamon, bupivacaine and lidocaine and tylenol all ineffective, fludrocortisone, Metoclopramide, orris root

Symptoms: Friday 2-26 had rapid heart rate despite taking ivabradine, fainted 3 times Sunday 2-28. All dysautonomia symptoms increased - sweating, extremities turning purple, syncope, indigestion, etc.

Other Meds: midodrine, metoprolol, ivabradine, Synthroid, Cytomel, progesterone, estradiol, vitamin C, B-complex, B-2, CoQ10, L-carnitine, biotin, selenium, B-12, D3, fish oil, calcium, magnesium, potassium, NMN, Allegra, alpha lipoic acid

Current Illness: Sinus congestion

ID: 1065457
Sex: M
Age: 30
State: PA

Vax Date: 02/24/2021
Onset Date: 02/24/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Patient was accidentally given a Pfizer COVID-19 vaccine for his second dose after receiving Moderna COVID-19 vaccine (Lot 028L20A) for his first dose on 1/20/21. Patient denies any adverse events post vaccination.

Other Meds:

Current Illness:

ID: 1065458
Sex: F
Age: 65
State: NY

Vax Date: 03/01/2021
Onset Date: 03/02/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies: none

Symptoms: None stated.

Other Meds: none

Current Illness: none

ID: 1065459
Sex: M
Age: 75
State: DC

Vax Date: 02/09/2021
Onset Date: 02/23/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies: Shellfish

Symptoms: large red rash next to vaccination site. No raised nodules. Didn't itch. No treatment. Eventually faded away

Other Meds: Benicar Linzess, CArbidopa-Levadopa, Lexipro

Current Illness:

ID: 1065460
Sex: F
Age: 52
State: KS

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies: Ibuprofen, prednisone, budesonide

Symptoms: Headache onset 24 hours after first dose. Headache onset 1 hour after second dose. Continued headache, body aches 12 hours post second does. Continued headache, body aches chills, nausea and fever (102 max temp) 18 hours post second dose. Body aches, chill and fever until approximately 40 hours post second does. Continued headache and nausea with headache becoming severe 54 hours post second dose.

Other Meds: None

Current Illness: None

ID: 1065461
Sex: M
Age: 64
State: OH

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data: none

Allergies: PCN, IVP dye, shellfish

Symptoms: ONSET 1 hour after injection. --Swelling of face/hands/arm/feet. Surface veins in hands were black. Tingling of tongue and throat. Severe headache. Body aches. Extreme fatigue. Pregressing over the three hour period - treated with Benedryl, caffeine, ibuprofin, bed rest for 48 hours. Symptoms cleared by 72 hours.

Other Meds: Beet root powder, hawthorn berry, zinc, multi vitamin, vitamine E, vitamin B 12

Current Illness: Cold sxs, covid test negative

ID: 1065462
Sex: F
Age: 63
State: FL

Vax Date: 02/18/2021
Onset Date: 02/18/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data: None

Allergies: None

Symptoms: Widespread Muscle pain, more so than with just fibromyalgia. lower back and hip pain making it hard to walk. Still hurting pretty bad after over a week. Either caused a fibromyalgia flare up or really affected my muscles. Never had the hip pain like this.

Other Meds: Synthroid, Cytomel, Vit C, Vit D, Zinc, Celebrex, Magnesium

Current Illness: None

ID: 1065463
Sex: F
Age: 56
State: AZ

Vax Date: 02/26/2021
Onset Date: 03/01/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies: none

Symptoms: nausea, terrible body pain, terrible headaches

Other Meds: duloxotine, prednisone, spirolactone, bupropion, cyclobenzaprine, metropinol, omeprazol, 81mg aspirin, prenatal vitamins, super B vitamin,

Current Illness: SSA Disability: non-alcohl liver cirhosis , hashimotos, RA (RD), tinitis, fibromyalgia, migraines, anemia, Degenerative Disc Disease, Chronic pain

ID: 1065464
Sex: F
Age: 73
State: GA

Vax Date: 02/26/2021
Onset Date: 02/27/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Chills and fever began at approx. 1:30 a.m. on February 27. Continued until late mid-day on March 1. Extreme weakness and nausea. Had no appetite. Very dry mouth. Fever lessened by evening of March 1. Weakness and feeling of lightheadedness continuing as of today, March 2, morning. No more nausea today. No fever today Able to eat small amount of food

Other Meds:

Current Illness:

ID: 1065468
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: joint pain; This case was reported by a consumer via interactive digital media and described the occurrence of joint pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced joint pain. On an unknown date, the outcome of the joint pain was unknown. It was unknown if the reporter considered the joint pain to be related to Shingrix. Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The patient received Shingrix and had joint pain. The reporter asked f it could be a side effect of the 2nd Shingrix.

Other Meds:

Current Illness:

ID: 1065469
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: arm be sore and red and itchy / Arm is itchy; arm be sore / Arm is itchy sore; arm be sore and red / Arm is itchy sore red; This case was reported by a consumer via call center representative and described the occurrence of itchy upper limbs in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced itchy upper limbs, pain in arm and erythema. On an unknown date, the outcome of the itchy upper limbs, pain in arm and erythema were unknown. It was unknown if the reporter considered the itchy upper limbs, pain in arm and erythema to be related to Shingles vaccine. Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The patient received Shingrix and arm became sore, red and itchy. The reporter asked how long would arm be sore, red and itchy.

Other Meds:

Current Illness:

ID: 1065470
Sex: F
Age:
State: NY

Vax Date: 01/21/2021
Onset Date:
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: arm soreness; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix with an associated reaction of pain in extremity (received 1st dsoe in October 2020, refer case US2021025199.). On 21st January 2021, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 weeks after receiving Shingrix, the patient experienced pain in arm. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the pain in arm was unknown. It was unknown if the reporter considered the pain in arm to be related to Shingrix. Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix and experiencing arm soreness in both arms, but more in the arm that was vaccinated in October. The reporter did not consent to follow up.; Sender's Comments: US-GLAXOSMITHKLINE-US2021025199:same reporter

Other Meds:

Current Illness:

ID: 1065471
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: SORE ARM; This case was reported by a consumer via and described the occurrence of pain in arm in a adult patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 6 months after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown. It was unknown if the reporter considered the pain in arm to be related to Shingrix. Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The patient received Shingrix and had sore arm. The patient got both doses 6 months apart and got it late in 2019. The patient also got the Pfizer 3 weeks apart. For tolerances of 2nd dose, refer case US2021AMR025854, reported by same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR025854:same reporter

Other Meds:

Current Illness:

ID: 1065472
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: SORE ARM; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a adult patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix with an associated reaction of pain in extremity (received 1st dose on unknown date, refer case US2021AMR025848). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced pain in arm. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the pain in arm was unknown. It was unknown if the reporter considered the pain in arm to be related to Shingrix. Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The patient received Shingrix and had sore arm. The doses received 6 months apart and got it late in 2019 and so far so good. The patient also got the Pfizer 3 weeks apart.; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR025848:same reporter

Other Meds:

Current Illness:

ID: 1065473
Sex: U
Age:
State: NY

Vax Date:
Onset Date:
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: last one was more painful; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Previously administered products included Shingles vaccine (1st dose received on unknown date) and Moderna Covid-19 vaccine (Received on unknown date). On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain. On an unknown date, the outcome of the pain was unknown. It was unknown if the reporter considered the pain to be related to Shingles vaccine. Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was captured as adult as per vaccine indication. The patient did not have shingles. The patient received the two doses and after last dose was more painful than the Moderna Coivd-19 vaccine.

Other Meds:

Current Illness:

ID: 1065474
Sex: U
Age:
State: AZ

Vax Date:
Onset Date:
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Got the 2 shots / Each time was very ill; This case was reported by a consumer via interactive digital media and described the occurrence of unwell in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced unwell. On an unknown date, the outcome of the unwell was recovered/resolved. It was unknown if the reporter considered the unwell to be related to Shingles vaccine. Additional events were reported as follows: The age at vaccination was not reported. The age group was not reported but was captured as per vaccine indication. The patient received 1st dose of Shingles vaccine and was ill. For tolerance of 2nd dose, refer case US2021AMR027665.; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR027665:Same reporter.

Other Meds:

Current Illness:

ID: 1065475
Sex: U
Age:
State: AZ

Vax Date:
Onset Date:
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Got the 2 shots / Each time was very ill; This case was reported by a consumer via interactive digital media and described the occurrence of unwell in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Previously administered products included Shingles vaccine with an associated reaction of malaise (received 1st dose on unknown date, refer case-US2021AMR027656). On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced unwell. Rechallenge with Shingles vaccine was positive. On an unknown date, the outcome of the unwell was unknown. It was unknown if the reporter considered the unwell to be related to Shingles vaccine. Additional events were reported as follows: The age at vaccination was not reported. The age group was not reported but was captured as adult as per vaccine indication. The patient received 2nd dose of Shingles vaccine and was ill.; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR027656:Same reporter.

Other Meds:

Current Illness:

ID: 1065476
Sex: F
Age:
State:

Vax Date: 02/13/2021
Onset Date:
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: After her 2nd shot she felt something trickle down her arm; Possible underdose; A spontaneous report was received from a healthcare professional concerning a female patient who was participating in the mRNA-1273 Emergency Use Program and experienced events like Vaccine under dose and Vaccination complication. The patient's medical history not provided. The patient's concomitant not provided On 13th FEB 2021, the patient received their second of two planned doses of mRNA-1273 intramuscularly in the anatomical location for prophylaxis of COVID-19 infection. The patient experienced onset of events of After her 2nd shot she felt something trickle down her arm, possible under dose, and Side effects from the 2nd vaccine were much less than the first. Treatment was not provided. Action taken with mRNA-1273 in response to the events was not reported. The outcome of the reported events was unknown.; Reporter's Comments: This report refers to a case of Vaccine underdose and exposure via skin for nRNA-1273 with no associated AEs.

Other Meds:

Current Illness:

ID: 1065477
Sex: F
Age:
State: PA

Vax Date: 02/15/2021
Onset Date: 02/15/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Some of the dose ran down the patient's elbow; dose running down patient's elbow; A spontaneous report (UNITED STATES) was received from a pharmacist concerning of a 27 years old, female patient, who received Moderna's COVID-19 vaccine, and who experienced dose of vaccine running down patient's elbow (accidental underdose) (exposure via skin contact). The patient's medical history was not provided. Concomitant product use was not provided by the reporter. On 15 Feb 2021, prior to the onset of the events, the patient received their second of two planned doses of mRNA-1273 (lot number 010M20A) intramuscularly for COVID-19 prophylaxis. During the administration, the vaccine ran down the patient's elbow, and the patient experienced accidental underdose and exposure via skin contact. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not provided. The outcome of the event was resolved on 15 Feb 2021.; Reporter's Comments: This report refers to a case of accidental underdose and exposure via skin for mRNA-1273 with no associated AEs.

Other Meds:

Current Illness:

ID: 1065478
Sex: F
Age:
State: VA

Vax Date: 01/13/2021
Onset Date: 02/03/2021
Rec V Date: 03/02/2021
Hospital: Y

Lab Data:

Allergies:

Symptoms: Viral meningitis; A spontaneous report from was received from reporter concerning a patient of unknown age who received Moderna's COVID-19 vaccine (mRNA-1273) on 13 Jan 2021. The patient's medical history was not provided. No relevant concomitant medications were reported. On13 January 2021, the patient received their first dose of mRNA-1273 (lot/batch: Unknown) intramuscularly in the unknown Anatomical location for prophylaxis of COVID-19 infection. Patient diagnosed with mild viral meningitis on 3rd February 2021. Patient experienced intense headaches and sickness. Patient got discharged on 12 February 2021. Treatment for the event included anti viral drip, Celebrex, Benadryl, Tylenol, Elavil. Action taken with mRNA-1273 in response to the events was not reported. The outcome of viral meningitis was not resolved.; Reporter's Comments: Very limited information regarding this event has been provided at this time. Further information has been requested.

Other Meds:

Current Illness:

ID: 1065479
Sex: U
Age:
State: NY

Vax Date: 02/12/2021
Onset Date: 02/12/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: dose given comprised of multiple vials; A spontaneous report was received from a healthcare professional concerning an unknown patient who received Moderna's COVID-19 vaccine (mRNA-1273) and stated that the dose given comprised of multiple vials No patient details were provided. The patient's medical history was not provided. No relevant concomitant medications were reported. On unknown date, prior to the onset of the events, the patient/patients received their first of two planned doses of mRNA-1273 (lot/batch: 031L20A) for prophylaxis of COVID-19 infection. The reporter stated that 12FEB2021 1 patient would have received a dose from multiple vials and on 13FEB2021 2-3 patients may have received doses from multiple vials. Laboratory details if provided. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. The outcome of the event ( dose given comprised of multiple vials ) was recovered/resolved..; Reporter's Comments: This case concerns a patient of unknown age and gender who had a nonserious unexpected event of Product preparation issue with mRNA-1273 (lot # 031L20A) without associated adverse events. Reporter stated a "pharmacy pre-filled syringes and combined the contents of multiple vials to make a single dose, and that multiple patients may have received doses from multiple vials". Very limited information regarding the events has been provided at this time. Further information has been requested.

Other Meds:

Current Illness:

ID: 1065480
Sex: F
Age:
State: NV

Vax Date: 01/15/2021
Onset Date:
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: patient has not received the second dose yet and more than 2 months has passed since first dose; A spontaneous report was received from a consumer concerning a female patient who experienced patient has not received the second dose yet and more than 2 months has passed since first dose. The patient's medical history was not provided. No concomitant products were provided. On 15-JAN-2021, the patient received her first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection. The patient was supposed to get the second dose on 12-FEB-2021, but the facility only had the Pfizer vaccine. The patient tried going to another distribution center but the patient could not get a dose. The patient had an appointment for the second dose on 25-MAR-2021, but that will be more than two months after the first dose. The patient was trying to get a different date for the second dose. Action taken with mRNA-1273 in response to the event was reported as unknown. The outcome of the event was considered resolved.; Reporter's Comments: This report refers to a case of patient has not received the second dose yet and more than 2 months has passed since first dose for mRNA-1273 (lot# unknown), with no associated adverse events.

Other Meds:

Current Illness:

ID: 1065481
Sex: F
Age:
State: NV

Vax Date: 02/16/2021
Onset Date: 02/16/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: concerned that didn't get the entire dose; during administration, some of the liquid dropped on arm; A spontaneous report was received from a nurse, who was also a female patient (age not reported), who received Moderna's COVID-19 vaccine (mRNA-1273) and during administration, some of the liquid dropped on arm (exposure via skin contact) so she was concerned that she didn't get the entire dose (accidental underdose). The patient's medical history was not provided. No concomitant product use was reported. The patient received their first of two planned doses of mRNA-1273 (batch number unknown) on an unknown date. On 16 Feb 2021, prior to the onset of events, the patient received their second of two planned doses of mRNA-1273 (batch number unknown) for prophylaxis of COVID-19 infection. On 16 Feb 2021, during administration of the vaccine, some of the liquid dropped on her arm so she was concerned that she didn't get the entire dose. Treatment information was not provided. The patient received both scheduled doses of mRNA-1273 prior to the events. Therefore, the action taken with the drug in response to the events was not applicable. The events, during administration, some of the liquid dropped on arm and was concerned that didn't get the entire dose, were considered recovered/resolved on 16 Feb 2021.; Reporter's Comments: This report refers to a case of accidental underdose and exposure via skin contact for mRNA-1273 (lot # unknown), with no associated AEs.

Other Meds:

Current Illness: No adverse event (No medical history provided)

ID: 1065482
Sex: M
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Received a double dose / pt received 1mL for the dose; A spontaneous report was received from a healthcare professional concerning a male patient of unknown age who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced a double dose/accidental overdose. The patient's medical history was not provided. No relevant concomitant medications were reported. On an unknown date, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection. The patient was given a double dose. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. At the time of this report, the outcome of the event patient received 1mL for the dose was recovered.; Reporter's Comments: This case concerns a male patient of unknown age who received their first of two planned doses of mRNA-1273 (Lot unknown), reporting Accidental overdose without any associated adverse events.

Other Meds:

Current Illness:

ID: 1065483
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: patient under the age of 18 received the 1st dose of the vaccine; A spontaneous report was received from a pharmacist concerning a patient under the age of 18 that received the first dose of Modern's COVID-19 vaccine (mRNA-1273) . The patient's medical history was not provided. No concomitant medications were reported. On an unknown date, the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) for prophylaxis of COVID-19 infection. No laboratory details were provided. No treatment information was provided. Action taken with mRNA-1273 in response to the events, patient under the age of 18 received the first dose of the vaccine, was not reported. The outcome of the event, patient under the age of 18 received the first dose of the vaccine, was considered recovered/resolved.; Reporter's Comments: This case concerns a patient under the age of 18 who received their first of two planned doses of mRNA-1273 (Lot unknown), reporting Product administered to patient of inappropriate age without any associated adverse events.

Other Meds:

Current Illness:

ID: 1065484
Sex: U
Age:
State: PR

Vax Date: 02/16/2021
Onset Date: 02/16/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Vials storage error; 10 patients were vaccinated from that vial; A spontaneous report was received from a pharmacist, concerning ten patients who were administered Moderna's COVID-19 vaccine from a vial temporarily stored at 17.7 ?F/product storage error and out of specification product use. The patients' medical histories were not provided. Concomitant product use was not provided by the reporter. On 16 Feb 2021, ten patients received one of two planned doses of mRNA-1273 (Batch number 029L20A) intramuscularly for prophylaxis of COVID-19 infection. On 16 Feb 2021, the freezer door at the pharmacy was left slightly open which resulted in a temperature increase to 17.7 ?F for one hour and 25 minutes. After visual inspection by the pharmacist, all vial were reportedly still frozen. The pharmacist thawed 1 vial, and 10 patients were vaccinated from that vial. The pharmacist noted that the temperature of the freezer containing the remaining 29 vials was -11.0 ?F at the time of reporting. Action taken with mRNA-1273 in response to the event was not provided. The event, 10 patients vaccinated from a vial temporarily stored at 17.7 ?F, was considered resolved on 16 Feb 2021.; Reporter's Comments: This report refers to a case of Product storage error (vaccine from a vial temporarily stored at 17.7 ?F, and administered to ten patients) for mRNA-1273, lot # 029L20A with no associated AEs.

Other Meds:

Current Illness:

ID: 1065485
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: received second dose of vaccine on day 27 instead of day 28; A spontaneous report was received from a consumer concerning a female patient (demographics not provided) who received the second dose of Moderna vaccine on day 27 instead of day 28. The patient's medical history was not provided. Concomitant product use was not provided by the reporter. On unknown date, the patient received their first of two planned doses of mRNA-1273. On unknown date, the patient received their second dose of mRNA-1273 (route and site of administration were not provided) for prophylaxis of COVID-19 infection. On an unknown date, the patient was administered the second dose of vaccine before day twenty-eight. Treatment information was not provided. The patient received both scheduled doses of mRNA-1273; therefore, action taken with the drug in response to the event is not applicable. The outcome of the event received second dose of vaccine on day 27 instead of day 28 was resolved.; Reporter's Comments: This report refers to a case of inappropriate schedule of vaccine administration for mRNA-1273 with no associated AEs.

Other Meds:

Current Illness:

ID: 1065486
Sex: F
Age: 53
State: MA

Vax Date: 02/15/2021
Onset Date: 02/15/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: administered a 0.3 ml dose instead of the 0.5 ml dose; A spontaneous report was received from a consumer concerning a 53-year-old, female patient who received Moderna's COVID-19 vaccine and was administered a 0.3 ml dose (MedDRA PT: Incomplete dose administered). The patient's medical history was not provided. Concomitant product use was not provided by the reporter. On 15 FEB 2021, the patient received their first of two planned doses of mRNA-1273 (Batch number: 011M20A) intramuscularly for prophylaxis of COVID-19 infection. On 15 Feb 2021, the patient received a call from the pharmacy where she received her vaccine. Patient reports that the lady giving the dose was not used to giving Moderna Covid-19 Vaccine and administered a 0.3 ml dose instead of the 0.5 ml dose. Treatment information was not provided/unknown. Action taken with mRNA-1273 in response to the event was unknown. The event, administered 0.3 ml dose, was considered recovered/resolved 15 Feb 2021.; Reporter's Comments: This report refers to a case of incorrect dose administered for mRNA-1273, with no associated AEs.; Sender's Comments: US-MODERNATX, INC.-MOD-2021-015255:Lnked case- Sister case

Other Meds:

Current Illness:

ID: 1065487
Sex: M
Age:
State: MA

Vax Date: 02/15/2021
Onset Date: 02/15/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Received a invalid dose of 0.3 ml; A spontaneous report, was received from a consumer (patient's sister), concerning a male patient of unknown age, unknown race and ethnicity, who was administered Moderna's COVID-19 vaccine (mRNA-1273), and resulted in patient received an invalid dose of 0.3 ml (underdose). The patient's medical history was not provided. Concomitant mediation was not reported. On 15 Feb 2021, prior to the onset of event, the patient received their first of two planned doses of mRNA-1273 (batch number: unknown), intramuscularly for the prophylaxis of COVID-19 infection. The patient's sister received a call from the pharmacy, and it was reported that the patient received Moderna COVID-19 Vaccine on 15 Feb 2021. The patient's sister reported that the lady giving the dose was not used to give Moderna Covid-19 Vaccine and administered a 0.3 ml dose to the patient instead of the 0.5 ml dose. Treatment information was not provided. Action taken with second dose of mRNA-1273 in response to the event was unknown. The event, received an invalid dose of 0.3 ml, was considered recovered/resolved on 15 Feb 2021.; Reporter's Comments: This report refers to a case of vaccine underdose administered to a male patient for mRNA-1273, (lot # not reported) with no associated AEs.; Sender's Comments: US-MODERNATX, INC.-MOD-2021-015236:Lnked case- Sister case

Other Meds:

Current Illness:

ID: 1065488
Sex: F
Age:
State: MA

Vax Date: 02/16/2021
Onset Date: 02/16/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Received 0.3 ml vaccine for first shot; A spontaneous report, was received from a consumer (patient), a female patient of unknown age, unknown race and ethnicity, who was administered Moderna's COVID-19 vaccine (mRNA-1273), and resulted in patient received 0.3 ml vaccine for first shot (underdose). The medical history of patient was not provided. Concomitant medication was not provided. On 16 Feb 2021, prior to the onset of event, the patient received their first of two planned doses of mRNA-1273 (batch number: unknown), intramuscularly for the prophylaxis of COVID-19 infection. The patient confirmed that she received her first shot of Moderna COVID-19 Vaccine on 16 Feb 2021, and got a call from the pharmacist that she got a lesser dose of 0.3 ml instead of 0.5 ml. But there was no problem if the patient received more than 0.25 ml, or more and the patient will still receive her second shot. The patient was worried and would like to know if the pharmacist said was true and if the dose given to her was effective or not and needs to be repeated. No treatment mediation information was provided. Action taken with second dose of mRNA-1273 in response to the event was unknown. The event, received 0.3 ml vaccine for first shot, was considered recovered/resolved on 16 Feb 2021.; Reporter's Comments: This report refers to a case of underdose for mRNA-1273, with no associated AEs.

Other Meds:

Current Illness:

ID: 1065489
Sex: M
Age: 42
State: MD

Vax Date: 02/16/2021
Onset Date: 02/16/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Arm has been sore; Chills; when she administered the vaccine she squirted the vaccine on me; nurse then drew up additional vaccine and administered 0.3mL; A spontaneous report was received from a consumer concerning a 42-year-old, male patient who was participating in the mRNA-1273 Emergency Use Program and experienced accidental underdose, extra dose administered, arm has been sore and chills. The patient's medical history not provided. Concomitant medications not provided. On 16-JAN-2021, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection. The patient reported that when he received the vaccine, the nurse squirted some of the liquid on him. He stated that she then went and got more vaccine and administered an additional 0.3mls. Additionally, he stated that on 17-JAN-2021, his arm was sore and he had chills. Treatment included Aleve. Action taken with mRNA-1273 in response to the events, accidental underdose, extra dose administered, arm has been sore and chills, was not provided. The events, accidental underdose and extra dose administered, were considered recovered/resolved. The outcome of the events, arm has been sore and chills, was unknown.; Reporter's Comments: This case concerns a 42 year old, male patient, who experienced a non-serious expected event of vaccination site pain, and chills, 2 days after receiving 1st dose of mRNA- 1273 (Lot# Unknown). This report also refers to a case of wrong technique in device usage process and accidental overdose for mRNA-1273 (lot # 028L20A), with no associated AEs. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1065490
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Received both doses 11 days apart; A spontaneous report, was received from a pharmacist, concerning a male patient of unknown age, unknown race and ethnicity, who was administered Moderna's COVID-19 vaccine (mRNA-1273), and resulted in patient received both doses 11 days apart (inappropriate schedule of product administration). The patient's medical history was not provided. No relevant concomitant medications were reported. On unknown date, prior to the onset of event, the patient received their second planned dose of mRNA-1273 (Lot number: unknown), intramuscularly for prophylaxis of COVID-19 infection. The pharmacist reported that the patient received both doses of Moderna COVID-19 vaccine 11 days apart. No treatment information was provided. Action taken with second dose of mRNA-1273 in response to the event was not applicable. The outcome of the event, received both doses 11 days apart, was considered as recovered on an unknown date.; Reporter's Comments: This case concerns a male patient of unknown age who received their second of two planned doses of mRNA-1273 (Lot unknown), reporting inappropriate schedule of product administration without any associated adverse events.

Other Meds:

Current Illness:

ID: 1065491
Sex: F
Age:
State: CO

Vax Date: 01/18/2021
Onset Date: 01/18/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Accidently given First dose to 17 year old; A spontaneous report , was received from a pharmacist, concerning a 17 years-old female patient, unknown race and ethnicity, who was administered Moderna's COVID-19 vaccine (mRNA-1273). The patient's medical history was not provided. No relevant concomitant medications were reported. On 18 Jan 2021, prior to the onset of event, the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown), intramuscularly for the prophylaxis of COVID-19 infection. The pharmacist called in to ask and confirm if he should give the second dose to a 17-year-old patient, who had been accidently given her first dose at the same pharmacy on 18 Jan 2021. The pharmacist did not have any additional patient identifier, or any other information related to this event. No treatment information was provided. Action taken with second dose of mRNA-1273 in response to the event was not reported. The outcome of the event, accidently given first dose to 17-year-old, was recovered on 18 Jan 2021.; Reporter's Comments: This report refers to a case of product administered to patient of inappropriate age (17 year old) for mRNA-1273 (lot number unknown) with no associated AEs reported.

Other Meds:

Current Illness:

ID: 1065493
Sex: F
Age: 73
State: TX

Vax Date: 01/27/2021
Onset Date: 01/27/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: black bruise at the injection site; concerned that vaccine was not administered intramuscularly; A spontaneous report was received from a patient concerning a 73-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and developed a big black bruise the size of a silver dollar around 3x3 inches at the injection site and was concerned maybe the vaccine was not intramuscularly administered. The patient's medical history was not provided. Concomitant medications reported included blood pressure medication and cholesterol medication, however, no product information was provided. On 27-Jan-2021, the patient received their first of two planned doses of mRNA-1273 (Batch Number: 004M20A) in the left arm for prophylaxis of COVID-19 infection. Patient reported that approximately 1-2 days following vaccine administration, she developed a big black bruise about the size of a silver dollar at the injection site. Additionally, she reported that she was concerned that the vaccine may not have been administered intramuscularly. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not reported. The event, developed a big black bruise the size of a silver dollar around 3x3 inches at the injection site, was considered recovering/resolving. The event, concerned maybe the vaccine was not intramuscularly administered, was considered recovered/resolved.; Reporter's Comments: This case concerns a 73-year-old, female patient who received their first of two planned doses of mRNA-1273 (Lot 004M20A) reporting Incorrect route of product administration and Vaccination site bruising. Based on the current available information and temporal association between the use of the product and the onset date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1065494
Sex: F
Age:
State: WI

Vax Date:
Onset Date:
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: 16 year old received the vaccine; A spontaneous report was received from a pharmacist concerning a 16-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced the event inappropriate age at vaccine administration. The patient's medical history was not provided. No relevant concomitant medications were reported. On an unknown date, prior to the onset of the events, the 16-year-old patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) for prophylaxis of COVID-19 infection. Laboratory details was not provided. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. The outcome of the event, inappropriate age at vaccine administration, was considered recovered/resolved.; Reporter's Comments: This case concerns a 16-year-old female patient who received their first of two planned doses of mRNA-1273 (Lot unknown), reporting Product administered to patient of inappropriate age without any associated adverse events.

Other Meds:

Current Illness:

ID: 1065495
Sex: F
Age: 67
State: FL

Vax Date: 02/18/2021
Onset Date: 02/18/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Vaccine administered to high in shoulder; Some of the vaccine dripped down arm; A spontaneous report was received from a consumer concerning a 68-year-old female patient, who received Moderna's COVID-19 vaccine to high in shoulder and some of the vaccine dripped down arm. The patient's medical history was not provided. No relevant concomitant medications were reported. On 18 Feb 2021, prior to the onset of the events, the patient received her first of two planned doses of mRNA-1273 (Lot number: unknown) intramuscularly in the left arm for prophylaxis of Covid-19 infection. The patient stated that the vaccinator administered vaccine too high in the shoulder and some of the vaccine dripped down arm. No further information was provided. Treatment information was unknown. Action taken with the second dose of mRNA-1273 in response to the event was not reported. The outcome of the events "some of the vaccine dripped down arm" and "vaccine administered to high in shoulder" was unknown.; Reporter's Comments: This report refers to a case of underdose, product administered at inappropriate site, and exposure via skin contact for mRNA-1273 (lot # unknown) with no associated AEs reported.

Other Meds:

Current Illness:

ID: 1065496
Sex: F
Age: 45
State: NY

Vax Date: 02/19/2021
Onset Date: 02/19/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Some of the vaccine dripped out; some of the vaccine dripped out; A spontaneous report was received from a Consumer concerning a 45 years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced device connection issue and vaccine under dose. The patient's medical history was not provided. No relevant concomitant medications were reported. On 19 Feb 2021, the patient received the first of two planned doses of mRNA-1273 (lot/batch: 030M20A) in the left non-dominant arm for prophylaxis of COVID-19 infection. On 19 Feb 2021, the patient experienced vaccine dripped out. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. The outcome of the events vaccine underdose and device connection issue was unknown.; Reporter's Comments: This report refers to a case of underdose and device connection issue for mRNA-1273 (lot # 030M20A) with no associated AEs reported.

Other Meds:

Current Illness:

ID: 1065497
Sex: M
Age:
State: CT

Vax Date: 02/19/2021
Onset Date: 02/19/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Vaccinated a pediatric patient; A spontaneous report was received from a healthcare professional concerning a 17 year old pediatric patient who received Moderna's COVID-19 vaccine (mRNA-1273) accidently. No relevant medical history is provided. No relevant concomitant medications were provided. On 19 Feb 2021, prior to the onset of the events, the patient received there first of two planned doses of mRNA-1273 (batch: unknown) for prophylaxis of COVID-19 infection. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. The outcome of the event vaccinated to pediatric patient was resolved.; Reporter's Comments: This report refers to a case of Inappropriate age at vaccine administration for mRNA-1273, lot # unknown, with no associated AEs.

Other Meds:

Current Illness:

ID: 1065498
Sex: M
Age:
State: CO

Vax Date: 02/09/2021
Onset Date: 02/09/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Vaccine leaked on the site of injection; Didn't receive full vaccine; A spontaneous report was received from a consumer concerning a 73-year-old, male patient, who received Moderna's COVID-19 Vaccine (mRNA-1273) and who experienced the vaccine leaked on the site of injection (vaccination site discharge) and didn't receive full dose of vaccine (underdose). The patient's medical history was not reported. The patient received their second of two planned doses of mRNA-1273 (Batch number: Batch number not provided) on 9 FEB 2021, intramuscularly for prophylaxis of COVID-19 infection. On 09 FEB 2021, Patient reported the vaccine leaked on the site of injection and thinks didn't receive full dose of vaccine. Action taken with the drug in response to the events was not applicable as the patient received both doses. The outcome of the events, vaccine leaked on the side of injection and patient didn't receive a full dose, was resolved on 09 Feb 2021.; Reporter's Comments: This report refers to a case of underdose and vaccination site discharge for mRNA-1273. There were no reported adverse events associated with this case.

Other Meds:

Current Illness:

ID: 1065499
Sex: F
Age: 41
State: IL

Vax Date: 01/26/2021
Onset Date: 01/26/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Administration lower than the deltoid muscle (she thinks); A spontaneous report was received from a nurse concerning a 41-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) administration lower than the deltoid muscle (Vaccine administered at inappropriate site). The patient's medical history was not provided. No relevant concomitant medications were reported. On 26 Jan 2021, prior to the onset of the event administration lower than the deltoid muscle, the patient received their second of two planned doses of mRNA-1273 (lot/batch: 038K20A) in the right arm for prophylaxis of COVID-19 infection. On 26 Jan 2021, the patient had her second dose of the vaccine on her right arm and she thinks the placement of vaccination was incorrect, lower than the deltoid muscle. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. The outcome of the event administration lower than the deltoid muscle was considered recovered.; Reporter's Comments: This report refers to a case of Vaccine administered at inappropriate site for mRNA-1273 (lot/batch: 038K20A) with no associated AEs.

Other Meds:

Current Illness:

ID: 1065500
Sex: M
Age: 34
State: CA

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: given 1ml dose instead of .5ml; A spontaneous report was received from a consumer concerning a 34-years-old, male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and given 1ml instead of .5ml/accidental overdose. The patient's medical history was not provided. No relevant concomitant medications were reported. On 28 Jan 2021, prior to the onset of the events, the patient received their second of two planned doses of mRNA-1273 for prophylaxis of COVID-19 infection. On 28 Jan 2021, the patient was given 1ml instead of .5ml. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not applicable. The outcome of the event given 1ml instead of .5ml was considered recovered.; Reporter's Comments: This report refers to a case of Accidental overdose for mRNA-1273. There were no reported adverse events associated with this case.

Other Meds:

Current Illness:

ID: 1065501
Sex: U
Age:
State: VA

Vax Date:
Onset Date:
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: vaccine administered to 16 year old; A spontaneous report was received from a physician assistant concerning a 16 year-old patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced vaccine administered to 16-year old. The patient's medical history was not reported. No relevant concomitant medications were reported. On an unknown date, 0 days prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 for prophylaxis of COVID-19 infection. On an unknown date, the 16 year old patient was administered the vaccine. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. The event, vaccine administered to 16-year old, was considered resolved on an unknown date.; Reporter's Comments: This is a case of 16-year-old female patient who was administered mRNA-1273 (Inappropriate age at vaccine administration) (Lot #: unknown). There was no associated adverse event reported for the event of Inappropriate age at vaccine administration.

Other Meds:

Current Illness:

ID: 1065502
Sex: F
Age: 16
State: MN

Vax Date: 12/28/2020
Onset Date: 12/28/2020
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: 16 year old female who received her first dose of the Moderna COVID-19 vaccine by accident; A spontaneous report was received from a consumer concerning a 16 year old female patients who received Moderna's Covid 19 vaccine (mRNA1273) first dose by accident. The patient's medical history was not provided. Concomitant product use was not provided/unknown by the reporter. On 28-DEC-2020 the patient received first of two planned dose of mRNA-1273 (Batch Number 026L20A) intramuscularly for prophylaxis of Covid 19 infection. Patient received first dose of the Moderna COVID-19 vaccine by accident on 28-DEC-2020. Action taken with mRNA-1273 in response to the event(s) was not provided/unknown. The outcome of the event, inappropriate age at vaccination were considered as recovered/resolved.; Reporter's Comments: This report refers to a case of inappropriate age at vaccine administration for mRNA-1273 (Batch Number 026L20A) with no associated AEs.

Other Meds:

Current Illness:

ID: 1065503
Sex: F
Age: 25
State: MN

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies: None

Symptoms: Moderna COVID-19 Vaccine EUA Full body aches, head aches, fever over 100 degrees, sweats and chills, nausea

Other Meds: Kyleena IUD Omeprazole Acyclovir Tums

Current Illness: None

ID: 1065504
Sex: F
Age: 33
State: VA

Vax Date: 02/27/2021
Onset Date: 03/02/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies: Ceclor, Zithromax

Symptoms: Soar throat and white growth on tongue appearing 2MAR21

Other Meds: Fluoxetine- 60mg Adderall XR 50mg Zyrtec 10mg Flonase Vitamin D, Fish oil, magnesium, vitamin c, zinc,

Current Illness:

ID: 1065505
Sex: F
Age: 55
State: MN

Vax Date: 02/26/2021
Onset Date: 03/02/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data: None

Allergies: Dust

Symptoms: I have fever, chills, sweats, headaches, body aches, swelling in my neck both sides. The right side was worse then the left. I am having a real hard time concentrating along with overwhelming fatigue. Today is March 2nd and I am still having all of these symptoms.

Other Meds: None

Current Illness: No

ID: 1065506
Sex: F
Age: 72
State: FL

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data: None yet

Allergies: Allergies to: shellfish,peanuts, soy, sulfites. Medications: tetrocycline, ibuprofen, mberpenicillan,sulfa, eryromycian, mobic, codene, cipro, leviquan.

Symptoms: Intermittent Tightness and Pain in Chest still 24 occuring 24 hours after injection.

Other Meds: Allegra, vitamin C, D3, Calcium, Zink

Current Illness: Post covid infection in December: "Long Hauler" chest pains, light headedness, shortness of breath

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm